Imaging Probe Development Center, National Heart, Lung, and Blood Institute, National Institutes of Health, Rockville, MD 20850, USA.
Nucl Med Biol. 2012 Jul;39(5):687-96. doi: 10.1016/j.nucmedbio.2011.12.008. Epub 2012 Feb 14.
The small molecule 2-(5-(dimethylamino)naphthalene-1-sulfonamido)-2-(fluoromethyl)butanoic acid (NST732) is a member of the ApoSense family of compounds, capable of selective targeting, binding and accumulation within cells undergoing apoptotic cell death. It has application in molecular imaging and blood clotting particularly for monitoring antiapoptotic drug treatments. We are investigating a fluorine-18-radiolabeled analog of this compound for positron emission tomography studies.
We prepared the tosylate precursor methyl 2-(5-(dimethylamino)naphthalene-1-sulfonamido)-2-(tosyloxymethyl)butanoate (4) to synthesize fluorine-18-labeled NST732. Fluorination reaction of the tosylate precursor in 1:1 acetonitrile:dimethylsulfoxide with tetrabutyl ammonium fluoride proceeds through an aziridine intermediate (4A) to afford two regioisomers: 2-(5-(dimethylamino)naphthalene-1-sulfonamido)-2-fluorobutanoate (5) and methyl 2-(5-(dimethylamino)naphthalene-1-sulfonamido)-2-(fluoromethyl)butanoate (6). Acid hydrolysis of the fluoromethylbutanoate (6) isomer produced NST732. As the fluorination reaction of the tosylate precursor proceeds through an aziridine intermediate (4A) and the fluorination conceivably could be done directly on the aziridine, we have separately prepared an aziridine precursor (4A). Fluorine-18 labeling of the aziridine precursor (4A) was performed with [(18)F]tetrabutyl ammonium fluoride to afford the same two regioisomers (5 and 6). The [18F]2-((5-dimethylamino)naphthalene-1-sulfonamido)methyl)-2-fluorobutanoic acid (NST732) was then obtained by the hydrolysis of corresponding [18F]-labeled ester (6) with 6 N hydrochloric acid.
Two regioisomers obtained from the fluorination reaction of aziridine were easily separated by high-performance liquid chromatography. The total radiochemical yield was 15%±3% (uncorrected, n=18) from the aziridine precursor in a 70-min synthesis time with a radiochemical purity>99%.
Fluorine-18-labeled ApoSense compound [18F]NST732 is prepared in moderate yield by direct fluorination of an aziridine precursor.
小分子 2-(5-(二甲基氨基)萘-1-磺酰胺基)-2-(氟甲基)丁酸(NST732)是 ApoSense 类化合物家族的成员,能够选择性靶向、结合和积累正在经历细胞凋亡的细胞。它在分子成像和血栓形成中具有应用,特别是用于监测抗凋亡药物治疗。我们正在研究这种化合物的氟-18 放射性标记类似物,用于正电子发射断层扫描研究。
我们制备了 tosylate 前体甲基 2-(5-(二甲基氨基)萘-1-磺酰胺基)-2-(tosyloxymethyl)丁酸(4)来合成氟-18 标记的 NST732。tosylate 前体在 1:1 乙腈:二甲亚砜中的氟化反应通过氮丙啶中间体(4A)进行,得到两种区域异构体:2-(5-(二甲基氨基)萘-1-磺酰胺基)-2-氟丁酸(5)和甲基 2-(5-(二甲基氨基)萘-1-磺酰胺基)-2-(氟甲基)丁酸(6)。氟甲基丁酸(6)的酸水解产生 NST732。由于 tosylate 前体的氟化反应通过氮丙啶中间体(4A)进行,并且氟化可以直接在氮丙啶上进行,我们已经分别制备了氮丙啶前体(4A)。用 [(18)F]四丁基氟化铵对氮丙啶前体(4A)进行氟标记,得到相同的两种区域异构体(5 和 6)。然后通过 6N 盐酸水解相应的 [18F]-标记酯(6)得到 [18F]2-((5-二甲基氨基)萘-1-磺酰胺基)甲基)-2-氟丁酸(NST732)。
氮丙啶氟化反应得到的两种区域异构体可以通过高效液相色谱轻松分离。在 70 分钟的合成时间内,从氮丙啶前体获得的总放射化学收率为 15%±3%(未校正,n=18),放射化学纯度>99%。
通过直接氟化氮丙啶前体制备了中等产率的氟-18 标记 ApoSense 化合物 [18F]NST732。